12.43
0.97%
+0.12
After Hours:
12.43
R1 RCM Inc. stock is currently priced at $12.43, with a 24-hour trading volume of 948.66K.
It has seen a +0.97% increased in the last 24 hours and a +2.30% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $12.40 pivot point. If it approaches the $12.48 resistance level, significant changes may occur.
Previous Close:
$12.31
Open:
$12.31
24h Volume:
948.66K
Market Cap:
$5.24B
Revenue:
$2.31B
Net Income/Loss:
$-33.40M
P/E Ratio:
-144.87
EPS:
-0.0858
Net Cash Flow:
$228.60M
1W Performance:
+2.90%
1M Performance:
+2.30%
6M Performance:
+16.49%
1Y Performance:
-25.88%
R1 RCM Inc. Stock (RCM) Company Profile
Name
R1 RCM Inc.
Sector
Industry
Phone
312-324-7820
Address
401 North Michigan Avenue, Suite 2700, Chicago, IL
R1 RCM Inc. Stock (RCM) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-03-24 | Initiated | Barclays | Overweight |
Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Dec-13-23 | Downgrade | JP Morgan | Overweight → Neutral |
Oct-19-23 | Upgrade | Truist | Hold → Buy |
Sep-22-23 | Initiated | Citigroup | Buy |
Aug-15-23 | Initiated | Cantor Fitzgerald | Overweight |
Apr-12-23 | Initiated | Stephens | Overweight |
Apr-11-23 | Initiated | Robert W. Baird | Outperform |
Feb-02-23 | Downgrade | Truist | Buy → Hold |
Jan-05-23 | Initiated | Canaccord Genuity | Buy |
Dec-07-22 | Upgrade | Guggenheim | Neutral → Buy |
Dec-06-22 | Initiated | Morgan Stanley | Equal-Weight |
Oct-24-22 | Initiated | Evercore ISI | Outperform |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-07-22 | Initiated | Truist | Buy |
Aug-01-22 | Resumed | JP Morgan | Overweight |
Jun-29-22 | Resumed | Barclays | Overweight |
Apr-14-22 | Initiated | Guggenheim | Neutral |
Feb-09-22 | Initiated | Deutsche Bank | Buy |
Dec-02-21 | Initiated | Jefferies | Buy |
Oct-14-21 | Initiated | JP Morgan | Overweight |
Sep-30-21 | Initiated | Barclays | Overweight |
Jul-22-21 | Initiated | BofA Securities | Buy |
Jun-02-21 | Initiated | Robert W. Baird | Outperform |
Aug-05-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
Jan-14-20 | Reiterated | Dougherty & Company | Buy |
Jan-10-20 | Initiated | Dougherty & Company | Buy |
Jan-22-19 | Initiated | KeyBanc Capital Mkts | Overweight |
Dec-10-18 | Initiated | Citigroup | Buy |
Sep-04-18 | Initiated | Chardan Capital Markets | Buy |
Apr-09-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
View All
R1 RCM Inc. Stock (RCM) Latest News
RBC Capital Reiterates R1 RCM (RCM) Outperform Recommendation - MSN
MSN
Amalgamated Bank Decreases Stake in R1 RCM Inc. (NASDAQ:RCM) - Defense World
Defense World
R1 RCM Inc. (NASDAQ:RCM) Shares Acquired by Van ECK Associates Corp - Defense World
Defense World
Albert Zimmerli Is The Director of R1 RCM Inc. (NASDAQ:RCM) And They Just Spent US$99k On Shares - Yahoo Canada Shine On
Yahoo Canada Shine On
Leerink Partnrs Weighs in on R1 RCM Inc.'s Q2 2024 Earnings (NASDAQ:RCM) - MarketBeat
MarketBeat
R1 RCM (NASDAQ:RCM) PT Lowered to $15.00 - Defense World
Defense World
R1 RCM Inc. Stock (RCM) Financials Data
R1 RCM Inc. (RCM) Revenue 2024
RCM reported a revenue (TTM) of $2.31 billion for the quarter ending March 31, 2024, a +17.61% rise year-over-year.
R1 RCM Inc. (RCM) Net Income 2024
RCM net income (TTM) was -$33.40 million for the quarter ending March 31, 2024, a +63.46% increase year-over-year.
R1 RCM Inc. (RCM) Cash Flow 2024
RCM recorded a free cash flow (TTM) of $228.60 million for the quarter ending March 31, 2024, a +345.81% increase year-over-year.
R1 RCM Inc. (RCM) Earnings per Share 2024
RCM earnings per share (TTM) was -$0.0741 for the quarter ending March 31, 2024, a +69.94% growth year-over-year.
R1 RCM Inc. Stock (RCM) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
SPARBY JOHN M. | President |
Mar 07 '24 |
Sale |
14.33 |
10,046 |
143,959 |
0 |
HENNEMAN JOHN B III | Director |
Aug 08 '23 |
Option Exercise |
2.61 |
50,000 |
130,500 |
122,114 |
HENNEMAN JOHN B III | Director |
Aug 08 '23 |
Sale |
17.17 |
50,000 |
858,650 |
72,114 |
Evans Richard B. Jr. | Principal Accounting Officer |
Jun 12 '23 |
Sale |
16.84 |
17,000 |
286,229 |
124,007 |
Evans Richard B. Jr. | Principal Accounting Officer |
Jun 09 '23 |
Sale |
16.69 |
12,000 |
200,280 |
141,007 |
About R1 RCM Inc.
R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. The company also provides modular services comprising physician advisory services, which assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; and revenue capture services, including charge capture, charge description master maintenance, and pricing services. It serves single or multi-hospital healthcare systems, and their respective affiliated ambulatory clinics and physician practice groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was founded in 2003 and is headquartered in Chicago, Illinois.
Cap:
|
Volume (24h):